Verve Therapeutics Statistics
Total Valuation
CHTH has a market cap or net worth of 603.58 million. The enterprise value is 1.12 billion.
Market Cap | 603.58M |
Enterprise Value | 1.12B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CHTH has 173.94 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Current Share Class | 173.94M |
Shares Outstanding | 173.94M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 0.09% |
Float | 172.57M |
Valuation Ratios
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.59 |
PB Ratio | 0.86 |
P/TBV Ratio | 0.86 |
P/FCF Ratio | n/a |
P/OCF Ratio | 12.05 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -91.96 |
EV / Sales | 2.96 |
EV / EBITDA | 13.34 |
EV / EBIT | 34.42 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.80.
Current Ratio | 2.00 |
Quick Ratio | 1.91 |
Debt / Equity | 0.80 |
Debt / EBITDA | 6.70 |
Debt / FCF | n/a |
Interest Coverage | 0.73 |
Financial Efficiency
Return on equity (ROE) is -1.70% and return on invested capital (ROIC) is 1.59%.
Return on Equity (ROE) | -1.70% |
Return on Assets (ROA) | 1.54% |
Return on Invested Capital (ROIC) | 1.59% |
Return on Capital Employed (ROCE) | 2.55% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.29 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CHTH has paid 689,000 in taxes.
Income Tax | 689,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.67% in the last 52 weeks. The beta is 0.72, so CHTH's price volatility has been lower than the market average.
Beta (5Y) | 0.72 |
52-Week Price Change | +15.67% |
50-Day Moving Average | 3.31 |
200-Day Moving Average | 3.21 |
Relative Strength Index (RSI) | 54.76 |
Average Volume (20 Days) | 3,784 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHTH had revenue of 379.00 million and -12.19 million in losses. Loss per share was -0.07.
Revenue | 379.00M |
Gross Profit | 92.85M |
Operating Income | 32.55M |
Pretax Income | -11.48M |
Net Income | -12.19M |
EBITDA | 83.99M |
EBIT | 32.55M |
Loss Per Share | -0.07 |
Balance Sheet
The company has 53.19 million in cash and 562.64 million in debt, giving a net cash position of -509.45 million or -2.93 per share.
Cash & Cash Equivalents | 53.19M |
Total Debt | 562.64M |
Net Cash | -509.45M |
Net Cash Per Share | -2.93 |
Equity (Book Value) | 699.48M |
Book Value Per Share | 3.72 |
Working Capital | 27.73M |
Cash Flow
Operating Cash Flow | 50.10M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 24.50%, with operating and profit margins of 8.59% and -3.22%.
Gross Margin | 24.50% |
Operating Margin | 8.59% |
Pretax Margin | -3.03% |
Profit Margin | -3.22% |
EBITDA Margin | 22.16% |
EBIT Margin | 8.59% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 2.95%.
Dividend Per Share | 0.10 |
Dividend Yield | 2.95% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 2.96% |
Earnings Yield | -2.02% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |